Academician of the Chinese Academy of Sciences and former director of the Shanghai Institute of Chinese Academy of Sciences Jiang Hualiang died of illness in Shanghai at the age of 57.The Chinese Academy of Sciences has not announced the specific cause of Jiang Hualiang.
According to the official website of the Chinese Academy of Sciences Shanghai Pharmaceutical Institute, Jiang Huarliang's funeral work team reported on the 23rd that the famous Chinese pharmacist, academician of Chinese Academy of Sciences, members of the Chinese Democratic Alliance, former director of the Shanghai Institute of Drugs of the Chinese Academy of Sciences, researcherMr. Jiang Huar Liang was invalid due to illness. He died at Shanghai at 15:54 on December 23, 2022 at the age of 57.
Jiang Huarliang's rigorous schooling, knowledgeable, responsible, and difficult to attack, dedicate all his energy in the basic research and new drug discovery of drug science, and actively promote the development of Chinese drug science.He devoted herself to science, realistic innovation, and rewarding after his life, and made an indelible outstanding contribution to the development of drug research and development and the development of pharmacy.
Jiang Hua Liang died early, and the employees and graduate students of the whole institute were very sad. They will hold a mourning activity and notify the time and place.
According to Xinhua News Agency at the end of January 2020, the Shanghai Institute of Drugs and Wuhan Virus Research Institute jointly discovered that the Chinese Academy of Sciences and the Wuhan Virus Research Institute preliminarily discovered that the Chinese medicine double Huanglian oral liquid can inhibit the new coronary virus.
Earlier, the anti -new coronary virus infection with pneumonia research emergency research team led by the Chinese Academy of Sciences Jiang Huaiang was launched by the Chinese Academy of Sciences.New research on new drug screening, evaluation and old medicine for the treatment candidate for the virus.At present, Shuanghuanglian Oral Liquid has conducted clinical research at Tongji Hospital of Shanghai Public Health Clinical Center and Tongji Hospital affiliated to Huazhong University of Science and Technology.
Later, Chinese official media such as the People's Daily Science and Technology Daily China Youth Daily reported that Shuanghuanglian oral liquid could inhibit the new crown virus, causing the public to buy a wave.
Caixin.com quoted experts from experts on February 220, 2020, and criticizing unsatisfactory clinical experiments to release Shuanghuang Lian oral liquid in suppressing the new crown virus is not advisable.
Li Ke, chief physician of the Department of Severe Medicine, Xiang'an Hospital affiliated to Xiamen University, said: "I will not use double Huanglian oral solution for patients or ordinary people.Release the message, I won't believe it! The so -called separation is not published in regular academic journals, but the so -called media. "
He said:" As a doctor, the biggest feeling is whether you can be scientific and regularClick! As a common people who know some science, there are too many scammers. In this case, uncertain things, it is best not to publish. The scientific research institute must be cautious! The scientific knowledge of ordinary people is still poor.As soon as the wind blows the grass, you can buy out of stock.
